Ketorolac Tromethamine
Recurrent Hairy Cell Leukemia
City of Hope Medical CenterPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Recurrent Hairy Cell Leukemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
HYDROMORPHON City of Hope Medical Center | Phase 1 | CC |
Benadryl City of Hope Medical Center | Phase 1 | CC |
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE City of Hope Medical Center | Phase 1 | CC |
FENTANYL City of Hope Medical Center | Phase 1 | CC |
RANITIDINE City of Hope Medical Center | Phase 1 | CC |
View all 11 →
Same molecule, other indications
Ketorolac Tromethamine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →